SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-342891
Filing Date
2021-11-30
Accepted
2021-11-30 07:13:55
Documents
15
Period of Report
2021-11-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d205347d8k.htm   iXBRL 8-K 24966
2 EX-99.1 d205347dex991.htm EX-99.1 26803
6 GRAPHIC g205347g1130045209186.jpg GRAPHIC 2399
7 GRAPHIC g205347g1130045209468.jpg GRAPHIC 2704
  Complete submission text file 0001193125-21-342891.txt   191064

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA meip-20211130.xsd EX-101.SCH 2895
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20211130_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20211130_pre.xml EX-101.PRE 11410
8 EXTRACTED XBRL INSTANCE DOCUMENT d205347d8k_htm.xml XML 3348
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 211458280
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences